Stocks/CHCT

CHCT

Community Healthcare Trust Incorporated
Real Estate·REIT - Healthcare Facilities
$17.22
$492M market cap
Claude Rating
4/10UNDERWEIGHT
Revenue
$122.4M
Free Cash Flow
$55.5M
Rev Growth
+4.8%
FCF Margin
45.3%
P/FCF
8.9x
EV/FCF
19.0x
Fwd EV/EBITDA
13.3x
Fair Value
$14.50
Upside
-15.8%

Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. The Company had investments of approximately $667.3 million in 131 real estate properties as of September 30, 2020, located in 33 states, totaling approximately 2.8 million square feet.

2-Year Price History

$17.38-9.4%
$14$16$18$20$22volJun 24Oct 24Jan 25May 25Sep 25Jan 26May 26

Quarterly Financials & Projections

Quarterly Waterfall ($ M)
PeriodRevEBITDAOpInNIOCFFCFCapExCashDebtSharesROICIntCovEV/EBITDA
Est2028-Q133.221.4--2.0--11.6-2.394.3----------
Est2027-Q433.521.9--2.7--12.7-2.782.7----------
Est2027-Q333.021.5--2.3--12.2-2.069.9----------
Est2027-Q232.520.8--2.1--11.7-2.157.7----------
Est2027-Q132.020.2--1.6--10.6-2.246.0----------
Est2026-Q432.520.8--2.3--12.4-3.335.5----------
Est2026-Q331.819.7--1.8--11.1-1.923.1----------
Est2026-Q231.218.7--0.9--9.4-2.512.0----------
Act2026-Q131.520.19.42.613.78.8-5.02.6564.727.05.9%3.0x12.6x
Act2025-Q431.033.89.314.415.529.5-14.03.3543.226.96.0%4.0x12.3x
Act2025-Q330.819.620.21.612.77.7-5.13.4534.126.913.3%2.8x15.7x
Act2025-Q229.15.1-0.7-12.613.89.6-4.24.9504.126.8-0.5%0.8x15.8x
Act2025-Q130.118.97.91.614.49.7-4.72.3500.026.75.2%3.0x15.7x
Act2024-Q429.319.38.21.815.710.5-5.24.4490.026.75.3%3.0x15.0x
Act2024-Q329.619.07.81.813.96.7-7.22.8477.826.75.1%3.0x16.7x
Act2024-Q227.56.5-4.6-10.416.79.5-7.20.7461.726.5-3.0%1.1x17.7x
Act2024-Q129.319.28.73.712.67.5-5.125.3452.726.35.6%3.8x14.3x
Act2023-Q429.119.89.64.614.36.8-7.53.5412.326.06.5%4.0x17.6x
Act2023-Q328.719.78.53.517.714.1-3.63.9405.325.55.5%4.2x19.8x
Act2023-Q227.820.210.06.616.712.9-3.82.6372.225.17.3%4.9x21.3x
Act2023-Q127.26.4-2.9-6.912.78.6-4.13.7369.324.2-2.2%1.6x21.8x
Act2022-Q425.317.08.75.215.411.7-3.711.2357.123.86.6%4.9x16.9x
Act2022-Q324.816.78.75.715.412.3-3.12.7314.923.67.4%5.5x--
Act2022-Q224.116.68.35.615.113.4-1.81.7295.523.67.4%6.0x--
Act2022-Q123.516.18.15.514.412.5-1.91.2273.423.67.6%6.1x--
Historical Valuation

Multiples vs the company's own history — cheap or rich relative to itself? Historical fiscal years, then TTM, then forward projections (E). Forward rows hold today's price against projected earnings, so the multiple compresses if the company grows into it.

YearPriceRev GrEBITDA %EBITDAEV/EBITDAEV/FCFP/EP/S
202226.9268.0%6616.9×22.6×35.4×8.0×
202321.13+15.5%58.5%6617.6×27.4×97.8×6.7×
202416.60+2.6%55.3%6415.0×28.0×n/m4.1×
202515.96+4.4%64.0%7712.3×16.9×80.8×3.4×
TTM17.22+5.0%64.2%790.0×0.0×0.0×0.0×
2027E17.22+7.0%0.6%10.0×0.0×0.0×0.0×

EBITDA in reporting-currency $M. Historical multiples use year-end market cap (split-adjusted price history); TTM & forward years use today's.

AI Analysis

LLM Evaluations

Claude4/10UNDERWEIGHTFV: $14.50

CHCT is a small-cap healthcare REIT trapped in a vicious cycle: its depressed stock price has shut off the ATM equity program, forcing capital recycling at unfavorable spreads while a troubled behavioral tenant across 6 properties generates negligible rent. The 13%+ dividend yield signals distress rather than value—AFFO payout ratios are near 100% on a cash basis, SBC exceeds net income, and the company has just $2.6M in cash with $30M in near-term commitments funded entirely by a credit revolver. Interest costs are set to spike as $75M in hedges expired. While the asset base has real value and management is attempting a disciplined capital recycling strategy, the lack of growth capital, high G&A burden (~21% of revenue), ongoing dilution, and binary behavioral tenant risk make this a value trap rather than an opportunity. Resolution of the behavioral tenant and a lower interest rate environment could provide upside, but the risk/reward skews negatively at current fundamentals.

Catalyst Successful closing of the behavioral hospital tenant transition to a new operator would immediately stabilize ~$3-4M in annual rent, boost occupancy by 200-300bps, and remove the largest overhang on the stock. A meaningful decline in interest rates could also re-open the ATM and restore the growth model.
Risk The behavioral hospital tenant transition falls through, forcing CHCT to take back 6 vacant properties with significant re-leasing costs, triggering further write-downs and potentially a dividend cut as cash flow coverage deteriorates below sustainable levels.
Trend
DETERIORATING
Mgmt
4/10
Quarter
4/10
Exp. Move
-5.0%

Latest Earnings Call

Transcript Summary

Community Healthcare Trust (CHCT) reported 2026 Q1 results characterized by steady revenue growth and a focus on capital recycling. Total revenue rose 4.8% year-over-year to $31.5 million, with AFFO reaching $0.56 per share. The company maintained its streak of quarterly dividend increases, raising the payout to $0.48 per share. A key highlight was the progress regarding a six-property behavioral hospital tenant transition; a new operator is currently in the definitive document phase for a takeover. While occupancy dipped slightly to 89.8%, management anticipates a rebound through active leasing and the commencement of new leases on redevelopment projects later in 2026. Investment activity included a $28.5 million acquisition of an inpatient rehabilitation facility at a 9.3% yield. The company is pivoting away from ATM equity issuance, instead funding its $99 million acquisition pipeline through the sale of non-core assets to manage its cost of capital effectively. Management emphasized that several redevelopment projects are nearing completion, which are expected to bolster NOI in the latter half of the year. During the Q&A, leadership addressed the timeline for tenant transitions and confirmed that lease escalators remain consistent at approximately 2%. Overall, CHCT remains focused on portfolio pruning and strategic growth.

Valuation & Metrics

Market Stats

Price$17.22
Market Cap$492M
Enterprise Value$1.1B
P/S Ratio4.0x
P/FCF8.9x
EV/FCF19.0x
FCF Margin (TTM)45.3%
FCF Yield11.3%
Dividend Yield (TTM)11.1%
Annual Dilution1.0%
CurrencyUSD

TTM Financial Snapshot

Revenue$122.4M
Net Income$6.1M
Free Cash Flow$55.5M

Revenue Growth (YoY)+4.8%
EBITDA Margin64.2%
Net Margin5.0%
FCF Margin45.3%
CapEx % of Revenue23.1%
SBC % of Revenue8.4%
ROIC6.2%
WC Change % Rev12.6%
Interest Coverage2.7x

DCF Fair Value Estimate

$1.52
-91.2% upside
Fair Enterprise Value$409M
− Net Debt$562M
= Fair Equity$41M
Revenue Growth3.7% → 2.0%
FCF Margin45.3% → 30.0%
Discount Rate15.0%
Terminal EV/FCF10.0x

Forward Outlook & Risk

Short Interest

Short % of Float2.4%
Short Shares0.6M
Days to Cover2.7
Change (vs Prior)-16.4%
Short % Float History
2.40%+0.40pp
2.0%2.5%3.0%3.5%4.0%04-3007-1509-1511-1401-1504-30

Options

Call IV (ATM)32%
Put IV (ATM)31%
ATM Spread1.2%
Call $OI (near money)$89K
Put $OI (near money)$13K
ATM ExpiryJuly 17, 2026 (56D)
ATM Strike$17.5
Major Expirations3
Near-money chain · July 17, 2026
StrikeCall Bid/AskCall OIPut Bid/AskPut OI
$7.50$9.60/$11.000--/$0.750
$10.00$7.10/$8.600--/$0.750
$12.50$4.70/$6.0050--/$0.7515
$15.00$2.40/$3.702$0.20/$0.7599
$17.50$0.75/$0.95190$0.65/$1.0525
$20.00--/$0.9545$1.75/$3.902
$22.50--/$0.750$3.40/$6.100
$25.00--/$0.750$6.50/$9.400
Snapshot: 2026-05-22

Forward Projections & Estimates

NTM Revenue Growth+4.2%
Forward FCF Margin34.0%
Forward EBITDA Margin62.3%
Forward P/FCF11.3x
Forward EV/FCF24.3x
Forward Int. Coverage2.6x
Model Risk Score7/10
Bankruptcy Odds10%
Est. Borrow Rate7.5%
Terminal EV/FCF10.0x
LT Growth2.0%
LT FCF Margin30.0%

Employees

Headcount36
Revenue / Employee$3,399,139
Gross Profit / Employee$2,134,528
2022: 31 → 2023: 37 → 2024: 36 → 2025: 35 (4% CAGR)

Institutional Ownership

Headline & net flow

NET BUYING

In Q1 2026 so far (quarter still filing), institutions are net buyers — bought 11.6% of float, sold 5.1%. 3 filers moved >1% of shares (3 buying, 0 selling).

Net flow · Q1 2026still filing
+6.5% of float (net)
Bought 11.6% · Sold 5.1%
92 filers reported (last quarter: 178)

Ownership composition

Active
47.9%(-6.2% YoY)
147 filers
hedge / family / endowment
Retail funds
Fidelity, Schwab, 401(k)
Passive
23.9%(-3.8% YoY)
9 filers
Vanguard, iShares, SPDR
Market makers
0.1%(-0.5% YoY)
5 filers
Citadel, Susquehanna
Insiders
10.2%
Form 4 — latest per insider
0%25%50%75%100%2022-062023-032023-122024-092025-062026-03
ActiveRetail fundsPassiveMarket makersRetail direct

Top holders

Fund$ valueCost basisΔ QoQΔ YoYα lifeFund AUM
BlackRock, Inc.Passive$42.7M$15.54+$335K−$1.0M-0.2%$5.69T
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.$31.5M$16.65+$20.0M+$20.7M+1.7%$73.71B
VANGUARD PORTFOLIO MANAGEMENT LLCPassive$23.4M$15.89+$23.4M+$23.4M$1.91T
VANGUARD CAPITAL MANAGEMENT LLCPassive$18.4M$15.89+$18.4M+$18.4M$4.04T
SYSTEMATIC FINANCIAL MANAGEMENT LP$17.9M$19.65+$18K+$1.3M-0.6%$4.33B
KENNEDY CAPITAL MANAGEMENT LLC$14.5M$17.02−$1.7M+$5.8M-1.5%$4.72B
Nuveen, LLC$14.0M$16.00+$7.6M+$3.8M+0.0%$368.63B
Invesco Ltd.$13.2M$16.17−$1.2M+$2.5M-0.2%$652.04B
STATE STREET CORPPassive$12.3M$25.91−$21K−$2.9M-0.2%$2.89T
GEODE CAPITAL MANAGEMENT, LLCPassive$12.0M$20.70+$176K+$838K+2.3%$1.61T
TWO SIGMA INVESTMENTS, LP$8.8M$18.46+$5.2M+$4.1M-0.9%$117.03B
Focus Partners Wealth$8.5M$18.39−$642K−$3.1M-0.7%$89.03B
AMERIPRISE FINANCIAL INC$8.4M$16.99+$728K+$8.4M-0.1%$430.96B
PALISADE CAPITAL MANAGEMENT LLC/NJ$8.0M$23.21−$236K+$883K-0.6%$2.81B
Aristotle Capital Boston, LLC$6.8M$18.26−$1.3M−$2.8M-1.6%$1.61B
CHARLES SCHWAB INVESTMENT MANAGEMENT INC$6.4M$17.84+$30K+$755K+0.7%$645.81B
DIMENSIONAL FUND ADVISORS LPPassive$6.2M$18.97+$127K+$816K-0.4%$480.92B
DEPRINCE RACE & ZOLLO INC$6.2M$23.34−$1.6M−$182K-1.1%$5.29B
ProShare Advisors LLC$6.0M$15.09−$261K+$6.0M-0.7%$67.49B
SEI INVESTMENTS CO$5.7M$17.39+$1.5M+$2.0M-0.4%$108.06B
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.

Trading behavior

Smart-money alpha (lifetime, %/qtr)BULLISH
Holders
-0.04%
avg per quarter
Holders (ex-self)
-0.03%
excl. this stock
Buyers (this Q)
+0.61%
56 buyers · $0.08B in
Sellers (this Q)
-0.33%
55 sellers · $0.03B out
alpha coverage: 88% of $ has a lifetime-alpha record
Holder behavior on this stocksource: stock
On big dips (−10%+)
+13.9%
how holders react when this stock falls
On quiet Qs
-8.7%
−10% to +10% baseline
On rallies (+10%+)
-21.4%
how they react when this stock rises
Holders' portfolio flow this Q
+3.9%
inflows — adds are organic
Sellers' portfolio flow this Q
-1.6%
Sellers shed AUM broadly — partly forced.
▸ Compare to holder-profile behavior (across all their stocks)
Holder dip (any stock)
-2.0%
Holder mid (any stock)
-1.6%
Holder rally (any stock)
-3.1%

Top Holders Over Time

5-year share-count history (top 10 holders by peak, incl. exited) + price

01.3M2.5M3.8M5.0M$14$18$23$27$312021-062022-062023-062024-062025-062026-03
hover the chart for per-quarter detailprice (right axis)
WESTWOOD HOLDINGS GROUP INCPRICE T ROWE ASSOCIATES INC /MD/19KBank of New York Mellon Corp258KT. Rowe Price Investment Management, Inc.CARDINAL CAPITAL MANAGEMENT LLC /CTMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.2.0MAristotle Capital Boston, LLC426KMILLENNIUM MANAGEMENT LLC287KPRUDENTIAL FINANCIAL INCMACQUARIE GROUP LTD

Analyst Coverage

Analyst Coverage
Price Targets
Last Year (3 analysts)$18.67840.0%
Current Price$17.22
Analyst Ratings
7
8
Buy: 7Hold: 8Sell: 1Consensus: Hold
Consensus Estimates
QuarterRevenueEBITDANet IncEPSEPS Range# Analysts
2025 Q331M20M2M$0.08$0.07 – $0.092
2025 Q431M20M3M$0.11$0.11 – $0.111
2026 Q131M20M3M$0.10$0.10 – $0.101
2026 Q232M20M3M$0.12$0.12 – $0.121
2026 Q332M21M3M$0.12$0.12 – $0.121
2026 Q432M21M4M$0.13$0.13 – $0.131
2027 Q133M21M4M$0.14$0.14 – $0.141
2027 Q234M22M4M$0.15$0.15 – $0.151
2027 Q334M22M4M$0.15$0.15 – $0.151
2027 Q435M23M4M$0.16$0.16 – $0.161

Corporate

Executive Compensation (2020-2022)

Direct Pay$60.4M
Incentive & Other$0.2M
Total Compensation$60.6M
% of Revenue17.1%

Insider Trading (last 12mo)

Open-market only (Form 4 P-Purchase + S-Sale). Excludes grants, option exercises, tax withholding, gifts.
Officers & directors
Buys ($, 12mo)
$252K
2 txns · 2 insiders · 15,815 sh
Sells ($, 12mo)
$0
0 txns · 0 insiders · 0 sh
Recent transactions
DateSideInsiderTitleSharesPriceDollarsOwned $
2025-11-04BUYCotman Cathrinedirector4,000$14.66$59K$552K
2025-05-28BUYVan Horn R. Lawrencedirector11,815$16.37$193K$1.45M

Order Flow (FINRA, ~3w lag)

22.8%retail+4.0pp
20.2%dark+3.3pp
week of 2026-04-13
10%15%20%25%30%35%24-1125-0225-0525-0825-1126-0226-04retail (non-ATS)dark (ATS)
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.

Revenue Breakdown

Revenue Segments

By Product (2019-Q3)
Product and Service, Other$0.5M-20%

Filing Risk Analysis

Filing Risk Scores

CHCT: Dividends cannibalizing cash flow while credit losses and non-cash accounting mask operational rot.

Overall Risk
8/10
Fraud
4/10
Dilution
7/10
Insolvency
6/10
Earnings Overstated
9/10
Hidden Liabilities
5/10
Legal
2/10
Audit Warnings
3/10
Hidden Upside
2/10
Contextually Acceptable
4/10

Counter-Thesis

Counter-Thesis & Recent News

📰 Recent News

Community Healthcare Trust reported a significant Q1 2026 earnings miss on May 5, 2026, posting an EPS of $0.07 compared to the $0.10 consensus estimate (MarketBeat). Total revenue grew slightly to $31.52 million, but margins were pressured by a $1.7 million reserve on interest receivable and an $8.7 million credit loss reserve specifically linked to a geriatric behavioral hospital tenant that occupies six properties (Stock Titan). Additionally, the company recorded $5.9 million in severance charges following an executive departure in late 2025.

🐻 Bear Case

The core bear case centers on a 'busted growth model' and unsustainable dividend coverage. Skeptics argue that CHCT’s Adjusted Funds From Operations (AFFO) is artificially inflated by aggressive add-backs, such as a $14.89 million stock compensation expense in 2025; without these, the true payout ratio exceeds 118% (Seeking Alpha). With the 'equity faucet' effectively shut off due to a low share price, the company is forced into higher-leverage debt and asset recycling, where dispositions are happening at high cap rates (~7.9%), making new acquisitions less accretive.

🚩 Red Flags

A major tenant operating six behavioral facilities has essentially stopped paying full rent, contributing only ~$300k in Q1 2026 against a much larger obligation (Seeking Alpha). Management has signaled that interest expenses will spike in Q2 2026 due to the expiration of $75 million in interest rate hedges that were previously locked in at lower rates (TipRanks). General and Administrative (G&A) expenses remain exceptionally high, consuming nearly 21% of total rental revenue, which is significantly higher than small-cap REIT peers.

⚔️ Competitive Threats

CHCT faces intense competition for quality healthcare assets in non-urban markets, which has led to a 'notable deceleration' in acquisition activity—dropping from $152 million in 2019 to just $28.5 million year-to-date in 2026 (Investing.com). As a small-cap player, CHCT lacks the economies of scale and cost-of-capital advantages of larger healthcare REITs, leaving it vulnerable to rising financing costs and operational inefficiencies.

💬 Customer Sentiment

Analyst sentiment has turned cautious, with a consensus 'Hold' rating as of May 2026. Recent downgrades include Zacks Research moving from 'Strong Buy' to 'Hold' (MarketBeat) and Truist Securities lowering its price target to $19.00 (Stock Analysis). Market participants appear skeptical of the 11%+ dividend yield, viewing it as a sign of financial distress and lack of confidence in future growth rather than a value opportunity.

Full Earnings Call Transcript

Full Earnings Call Transcript — Q1 • 2026-05-06

Operator: Welcome to Community Healthcare Trust Incorporated 2026 First Quarter Earnings Release Conference Call. On the call today, the company will discuss its 2026 first quarter financial results. It will also discuss progress made in various aspects of its business. Following the remarks, the phone lines will be opened for a question and answer session. The company's earnings release was distributed last evening and has also been posted on its website chct.reip. The company wants to emphasize that some of the information that may be discussed on this call will be based on information as of today, 05/06/2026, and may contain forward-looking statements that involve risks and uncertainty. Actual results may differ materially from those set forth in such statements. For a discussion of these risks and uncertainties, you should review the company's disclosures regarding forward-looking statements in its earnings release as well as its risk factors and MD&A in its SEC filings. The company undertakes no obligation to update forward-looking statements whether as a result of new information, future developments, or otherwise, except as may be required by law. During this call, the company will discuss GAAP and non-GAAP financial measures. A reconciliation between the two is available in its earnings release, which is posted on its website. Call participants are advised that this conference call is being recorded for playback purposes. An archive of the call will be made available on the company's Investor Relations website for approximately 30 days. It is the property of the company. This call may not be recorded or otherwise reproduced or distributed without the company's prior written permission. Now I would like to turn the call over to David H. Dupuy, CEO of Community Healthcare Trust Incorporated.
David H. Dupuy: Thank you very much. Good morning, everyone, and thank you for joining us today. For the 2026 first quarter conference call. On the call with me today is William G. Monroe, our Chief Financial Officer, Leanne Stack, our Chief Accounting Officer, and Mark Kearns, our Senior Vice President of Asset Management. Our earnings announcement and supplemental data report were released last night and furnished on Form 8-Ks along with our quarterly report on Form 10-Q. In addition, an updated investor presentation was posted to our website last night. During the first quarter, the behavioral hospital operator, a tenant in six of the company's properties, paid rent of approximately $300 thousand, an increase of $100 thousand over last quarter. On 07/17/2025, this tenant signed a letter of intent for the sale of the operations of all six of its hospitals to an experienced behavioral health care operator and is under exclusivity with that buyer. The buyer is finalizing legal and business due diligence and has entered the drafting phase of the definitive purchase documents, including new leases on the six hospitals owned by the company. We continue to maintain frequent, productive communication with the buyer's team to advance the closing process. While the transaction is progressing, we cannot provide specific timing or certainty that it will close. However, we remain committed to providing further updates as the process moves forward. We had a busy first quarter from both an operations and a capital recycling perspective and continue to be selective from an acquisition standpoint. Our occupancy decreased from 90.6% to 89.8% during the quarter due to lease terminations. However, our leasing team is very busy with renewals and new leasing activity and we expect leased occupancy to grow next quarter. Our weighted average lease term increased slightly from 7.0 to 7.1 years, and our asset management team continues to do a great job serving our tenants while focusing on property operating costs. We have three properties that are undergoing redevelopment or significant renovations with long-term tenants in place once the redevelopment or renovations are complete. The largest of these projects, a behavioral healthcare facility, received its certificate of occupancy in March. Due to health care licensure requirements, we expect this property to commence its lease and contribute NOI during 2026. During the first quarter, we acquired an inpatient rehabilitation facility after completion of construction for a purchase price of $28.5 million. We entered into a new lease with a lease expiration in 2044 and an anticipated annual return of approximately 9.3%. We also have signed definitive purchase and sale agreements for four properties to be acquired after completion and occupancy for an aggregate expected investment of $99 million. The expected return on these investments should range from 9.1% to 9.75%. We expect to close on two of these properties in 2026 and the remaining two in 2027. In February, we sold one building in Fort Myers, Florida and received net proceeds of approximately $5.2 million, resulting in a small loss on the property sale. We also received net proceeds of approximately $700 thousand from the disposition of a property in 2025. We did not issue any shares under our ATM last quarter. However, we continue to evaluate capital recycling opportunities and we would anticipate having sufficient capital from selected asset sales, coupled with our revolver availability, to fund near-term acquisitions. Going forward, we will evaluate the best uses of our capital, all while maintaining modest leverage levels. To wrap up, we declared our first quarter dividend and raised it to $0.48 per common share. This equates to an annualized dividend of $1.92 per share, and we are proud to have raised our dividend every quarter since our IPO. That takes care of the items I wanted to cover, so I will hand things off to Bill to discuss the numbers.
William G. Monroe: Thank you, Dave. I will now provide more details on our first quarter financial performance. I am pleased to report total revenue grew from $30.1 million in 2025 to $31.5 million in 2026, representing 4.8% annual growth over the same period last year. On a quarter-over-quarter basis, total revenue grew 1.9%, primarily from higher rental income from our recent acquisitions and higher property operating expense recoveries, partially offset by recent capital recycling dispositions and net leasing activity. Moving to expenses, property operating expenses increased by approximately $360 thousand quarter over quarter to $6.4 million for 2026. This increase was a result of seasonally higher snow plow and utility expense at several properties that we typically see in January and February in particular. Total general and administrative expense was $5.1 million in 2026, which was approximately $330 thousand higher quarter over quarter, primarily as a result of higher noncash amortization of deferred compensation and our typical first-quarter adjustments due to the timing of annual employee salary increases, employer HSA and 401(k)s contributions, and employer tax payments. On a year-over-year basis, G&A did not increase from the same $5.1 million in the first quarter 2025. Interest expense decreased by $160 thousand quarter over quarter to $6.8 million in 2026 due to two fewer days in the first quarter and slightly lower floating rates on our revolving credit facility. I will note that we expect our second quarter interest expense to be higher, however, based on an additional day in the second quarter, a full quarter of our current revolver balance which includes net borrowings from our inpatient rehabilitation facility acquisition in February, and the expiration in late March of $75 million of interest rate hedges. Moving to funds from operations, FFO in 2026 was $13.4 million, a 5.8% increase year over year compared to the $12.7 million of FFO in 2025. On a diluted common share basis, FFO increased $0.02 year over year from $0.47 in 2025 to $0.49 in 2026, and remained the same quarter over quarter from the $0.49 of FFO in 2025. Adjusted funds from operations, or AFFO, which adjusts for straight-line rents and stock-based compensation, totaled $15.4 million in 2026, a 4.1% increase year over year compared to the $14.7 million of AFFO in 2025. AFFO on a diluted common share basis was $0.56 in 2026, which was $0.01 higher both year over year and quarter over quarter from the $0.55 of AFFO in 2025. That concludes our prepared remarks. Dorwin, we are now ready to begin the question and answer session.
Operator: We will now open the call for questions. Please pick up your handset before pressing any keys. At this time, we will pause momentarily to assemble our roster. Our first question comes from Alexander Goldfarb with Piper Sandler. Please go ahead.
Alexander Goldfarb: Thank you, and good morning down there. Dave, you made some promising comments about the Assurance hospital transfer. It sounds like things are progressing, sort of getting in late stages. Can you just give a little bit more color? Do you feel like we are getting close to the end, or is this sort of typical government work where you have to enjoy the process? And at this point, based on the shot clock, you are like, okay, we should be at the point of the shot clock where this should be coming to a conclusion.
David H. Dupuy: Hey, Alex. Thanks for the question. We are feeling like we have definitely made some progress over the last quarter. Some of the roadblocks that we have seen, as you have alluded to, have related to getting some confirmation on some outstanding liabilities from a couple of the various governing bodies that pay. In particular, as it relates to Ohio Medicaid, firming up the amount that is owed. But we do feel like we are making good progress. The company is highly engaged, the buyer is highly engaged in the process, and we do feel like we are hopefully going to get final confirmation on timing and everything very shortly. As I said in the prepared remarks, we are currently trading documents and purchase agreements, and we would anticipate getting this in a good place, hopefully, in the next quarter.
Alexander Goldfarb: Okay. That is certainly good to hear. Second question is, obviously, housing is all the rage these days, and MOB, I think your traditional property types, may not be as in vogue, at least when you look at the public stock prices. When you look in the market for acquisitions, is that the same that you see in the private market? Or is your acquisition pipeline coming down mainly relative to your cost of capital? I am also trying to understand what is going on in valuation land and if all the health care private capital is heading only to senior housing, and your traditional target class remains still very attractive, and therefore your decision to pull the pipeline down is more based on just your cost of capital versus everything once again getting bid up and therefore there is less product of interest to you.
David H. Dupuy: No, it really has to do with the latter, Alex. We see a number of acquisitions. We continue to have investment committee every couple of weeks where we go through opportunities, and if we were in a different position and were not doing capital recycling and having to sequence those asset sales in order to acquire new assets—because we do not want to raise capital through our ATM—we would definitely see the types of properties and the types of opportunities that we would like to invest in. What we are doing in terms of focusing on capital recycling is using this as an opportunity to do two things. Obviously, we are using this as an opportunity to trim some of the properties that are in less attractive markets. A lot of these facilities that we sold, we sold five properties in 2025; we sold another one in 2026. We are using this as an opportunity to really prune the portfolio and improve the portfolio. It is not the most fun in terms of selling a property in order to buy properties, but that is what we are going to focus our time and efforts on. What we expect is in the second half of the year, as some of these redevelopment projects and other things that we have been working on come online, we would expect to start posting AFFO growth, and we hope that is recognized as a positive in the marketplace and puts us in a position to start doing what we have been doing historically as a company, which is not just growing the portfolio performance through leasing, but also growing the portfolio through acquisitions.
Operator: Thanks, Alex. Our next question comes from Jim Kammert with Evercore. Please go ahead.
Jim Kammert: Hi. Good morning. Thank you. The acquisition you noted was quoted at about a 9.3% yield, I believe. Is that a GAAP or a cash yield? And if GAAP, I am trying to understand what are the representative annual escalators on that long lease, and are they representative of the other four assets in the pipeline?
David H. Dupuy: That is a cash yield, that 9.3% cap rate. Jim, you were not coming through very clearly. Are you asking what the escalators are on that property?
Jim Kammert: Yes, sorry, Dave. Thank you. What are the escalators, and are they representative of the other four assets?
David H. Dupuy: Yes. They are 2% escalators and would be consistent with the other ones that are in the pipeline.
Jim Kammert: Great. That is all I had. Thank you.
Operator: We have no further questions at this time. I would now like to turn the conference back over to management for closing comments. Over to you.
David H. Dupuy: Great. Thanks, Dorwin, and thank you, everybody, for dialing in. We hope to see many of you at NAREIT coming up in June.
Operator: Thank you. The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.